Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
11 studies found for:    nvn1000 acne
Show Display Options
Rank Status Study
1 Completed A Phase 2, 3 Arm Study of NVN1000 Gel and Vehicle Gel in Subjects With Acne
Condition: Acne Vulgaris
Interventions: Drug: NVN1000 1% Gel;   Drug: NVN1000 4% Gel;   Drug: Vehicle Gel
2 Completed A Phase 1 Study Evaluating Safety and Tolerability of NVN1000 Gel
Condition: Acne Vulgaris
Interventions: Drug: NVN1000 4% Gel;   Drug: Vehicle Gel
3 Completed Study of NVN1000 Topical Gel and Topical Gel Vehicle in the Treatment of Moderate to Severe Acne Vulgaris
Conditions: Acne Vulgaris;   Acne
Interventions: Drug: NVN1000 Topical Gel;   Drug: Topical Gel Vehicle
4 Completed Cutaneous Tolerability and Safety of NVN1000 Topical Gel in Healthy Volunteers
Condition: Acne Vulgaris
Interventions: Drug: 2% NVN1000 Topical Gel;   Drug: 4% NVN1000 Topical Gel;   Drug: 8% NVN1000 Topical Gel;   Drug: Vehicle Topical Gel
5 Completed A 2 Period Cross-over Pharmacokinetic Study of SB204 in Acne Vulgaris
Condition: Acne Vulgaris
Interventions: Drug: SB204;   Drug: Vehicle Gel
6 Completed A Phase 1, 3 Day Study of Safety and Tolerability of NVN1000 Topical Gel in Healthy Volunteers
Condition: Acne Vulgaris
Interventions: Drug: Topical Gel Vehicle;   Drug: 8% NVN1000 Topical Gel;   Drug: 8% NVN1000 Topical Gel and moisturizer
7 Active, not recruiting P3 Long Term Safety Study of Once Daily SB204 in Acne
Condition: Acne Vulgaris
Intervention: Drug: SB204 4%
8 Active, not recruiting Pharmacokinetics of Topical SB204 in Adolescents With Acne Vulgaris
Condition: Acne Vulgaris
Intervention: Drug: SB204 4%
9 Active, not recruiting P3 Study in Acne Comparing Once Daily SB204 and Vehicle
Condition: Acne Vulgaris
Interventions: Drug: SB204 4%;   Drug: Placebo (vehicle)
10 Active, not recruiting P3 Study Comparing Once Daily SB204 and Vehicle Gel in Acne
Condition: Acne Vulgaris
Interventions: Drug: SB204 4%;   Drug: Placebo
11 Completed A Thorough ECG Study in Subjects With Acne Vulgaris Treated With SB204
Condition: Acne Vulgaris
Interventions: Drug: SB204;   Drug: SB204 8% or 12%;   Drug: Moxifloxacin;   Drug: Placebo

Study has passed its completion date and status has not been verified in more than two years.